iCAD's Xoft Axxent electronic brachytherapy (eBx) system


September 11, 2014 — iCAD Inc. will debut the company's latest technological advances and present updates on clinical data and patient outcomes using the Xoft Axxent electronic brachytherapy (eBx) system in the treatment of cancer during the upcoming American Society for Therapeutic Radiology and Oncology (ASTRO) meeting, Sept. 14-17.

Throughout the meeting iCAD will also showcase its expanded and comprehensive software and service offerings following the recent acquisitions of DermEbx and Radion, and will highlight innovations in technology with live product demonstrations of its Xoft system at booth #1938.

"This is a very exciting year for iCAD as we have significantly expanded our position as the industry's leading comprehensive solution provider in eBx. We look forward to outlining the elements of our new solutions and services and to giving customers a hands-on experience with our recent advances to the technology platforms, including the debut of our Axxent SPX controller, the latest extension of the Xoft system product line," said Ken Ferry, president and CEO of iCAD. "With our progress this year, iCAD is uniquely positioned to provide significant technology and service advantages to our valued customers and their patients."

"We continue to be encouraged by the positive data presented on the Xoft system for the treatment of non-melanoma skin cancer, as it further demonstrates the system's distinct clinical and cosmetic advantages," added Ferry.

During ASTRO iCAD will debut the new Axxent SPX controller, the latest extension of the Axxent product line. The Axxent SPX controller features a streamlined design to support enhanced mobility and flexibility for delivery of electronic brachytherapy treatment in a wider range of healthcare settings, including smaller treatment rooms. The controller also features new software and an enhanced barcode scanning function that offers significant workflow benefits and improved technology support for HIPAA compliance. These features are also now available on the multiplatform Axxent MPX controller, which remains commercially available as the company's platform product approved for use in all indications including breast intraoperative radiation therapy (IORT), breast accelerated partial breast irradiation (APBI), skin, endometrial and cervical cancer treatments.

"Electronic brachytherapy allows radiation oncologists to expand the reach of HDR [high-dose-rate] brachytherapy beyond conventional shielded vaults. It inherently offers safety for patients and personnel, target flexibility for challenging anatomic areas and fine radiation dose control. The new streamlined design may be easier to integrate into smaller spaces in many clinical facilities," said Rakesh Patel, M.D., medical director at the Targeted Radiation Institutes in the East and South Bay Areas in California.

For more information: www.xoftinc.com, www.icadmed.com


Related Content

News | Radiation Oncology

May 2, 2025 — GE HealthCare has announced an intended expansion of its radiation oncology portfolio as well as the ...

Time May 03, 2025
arrow
News | Radiology Education

April 21, 2025 — On June 20, the American Society of Radiologic Technologists (ASRT) will award Life Member status to ...

Time April 21, 2025
arrow
News | Radiology Business

April 16, 2025 — According to a new report, the U.S. Radiotherapy Market is projected to reach $2.49 billion by 2030 ...

Time April 17, 2025
arrow
News | ASTRO

March 14, 2025 — Another pivotal milestone in the nation’s fight against cancer recently took place with the ...

Time March 17, 2025
arrow
News | Computed Tomography (CT)

Royal Philips recently received 510(k) clearance from the US Food and Drug Administration (FDA) for its detector-based ...

Time November 13, 2024
arrow
News

Aug. 5, 2024 — Researchers from The University of Texas MD Anderson Cancer Center have demonstrated that adding ...

Time August 09, 2024
arrow
News | PET-CT

July 31, 2024 — In a head-to-head comparison with FDG PET/CT, FDG PET/MRI demonstrated comparable or superior diagnostic ...

Time July 31, 2024
arrow
Feature | Radiation Oncology | By Christine Book

News emerging from several leading organizations and vendors in the radiation therapy arena came in at a fast pace in ...

Time July 30, 2024
arrow
News | Radiation Oncology

July 11, 2024 — The American Society for Radiation Oncology (ASTRO) issued the following statement from Jeff M ...

Time July 11, 2024
arrow
News | Prostate Cancer

July 11, 2024 — GE HealthCare’s MIM Software, a global provider of medical imaging analysis and artificial intelligence ...

Time July 11, 2024
arrow
Subscribe Now